David Joyner

President, Chief Executive Officer and Chair of the Board CVS Health

Last Reviewed: October 1, 2026

Executive Summary

David Joyner has led CVS Health since October 2024 and became Chair of its board in January 2026. He is a pharmacy benefits veteran: he started at Aetna in 1986, joined Caremark in 1993 and spent most of his career in the businesses that became CVS Caremark, before running CVS’s Pharmacy Services segment. As chief executive he oversees a company of insurance plans, pharmacies, clinics and health services that serves nearly 185 million people. In the second quarter of 2026 CVS grew revenue 7.3 percent to $106.1 billion and raised its full-year guidance. CVS Health ranked No. 6 on the 2026 Fortune 500.

Career Highlights

• President and Chief Executive Officer of CVS Health since October 2024; Chair since January 2026.
• Executive Vice President and President of Pharmacy Services, January 2023 to October 2024.
• Advisor to health care companies including gWell and Podimetrics, 2020 to 2023.
• Executive Vice President, Sales and Account Services, CVS Caremark, until December 2019.
• Began his career at Aetna in 1986; joined Caremark Prescription Services in 1993.

Professional Journey

Joyner earned a bachelor’s degree in finance at the Rawls College of Business at Texas Tech University. He began his career at Aetna in 1986 as an employee benefit representative and joined Caremark Prescription Services in 1993.

He held a series of roles at CVS Health and its predecessors, including Executive Vice President of Sales and Account Services at CVS Caremark, through December 2019. From 2020 to 2023 he advised health care companies, including the wellness technology company gWell and the diabetic foot care company Podimetrics.

In January 2023 he returned to CVS Health as Executive Vice President and President of Pharmacy Services, running its pharmacy benefit manager, CVS Caremark. In October 2024 he became President and Chief Executive Officer, and on 1 January 2026 he also became Chair of the Board.

For the second quarter of 2026 CVS reported revenues of $106.1 billion and raised its full-year earnings and cash flow guidance. Joyner said the company’s businesses were working together “to deliver a technology-powered care engagement experience”. He has served on the advisory council of Texas Tech’s Rawls College of Business since July 2020.

Education

Texas Tech University, Rawls College of Business

Bachelor’s degree, Finance